STOCKTON, CALIFORNIA/January 27, 2013 / Newswire/ — Viratech Corp. (OTC:VIRA) announced today that Cancer.im’s first of 235 books to be released on Amazon’s Kindle platform, focusing on Cancer, Find and Stop Breast Cancer , by Dr. Kevin Buckman, has achieved number 1 best-seller status for both Breast Cancer and Oncology categories. You can purcase the breast cancer book here:
Find and Stop Breast Cancer is the result of decades of research by Dr. Buckman in the field of breast cancer. The book provides information geared toward making a difference in early diagnosis and treatment, and focuses much of its content on prevention of breast cancer and treatment alternatives. The book Find and Stop Breast Cancer also addresses what every woman needs to know about the prevention and treatment of breast cancer.
According to the book, early diagnosis is key for success in breast cancer. Finding breast cancer at stage 0 has a greater than 93% survival rate, however, the exact opposite is true for stage 4 breast cancer where survival rate over 5 years is only 15%.” A explanatory video of the book can be seen here: http://www.youtube.com/watch?v=JxaEELNlENM
About Cancer.im
Through its experience-based search engine and technology, Cancer.im’s goal is to become the primary resource on the web for people affected by cancer, for the purpose of making a difference in their own lives and the lives of others. http://www.youtube.com/watch?v=dz1tHRb3wvU Cancer.im’s mission is to empower every cancer patient, with the power to research their disease and to find, organize, and manage their own cancer support network at no charge to them. The goal of these support networks is to assist the patient in conserving needed energy by reducing the burden associated with their own daily trials and tribulations. Cancer.im will strive to convert this saved energy into a higher level of patient activity and a stronger determination to fight their disease.
In addition Cancer.im is seeking new cancer researchers who wish to leverage its intellectual property and social network platform for the purpose of creating new distribution and engagement channels.
About Viratech Corp.
Based in Stockton, California, Viratech Corp. has created an open source biotech research and development platform. This unique platform leveraging the utility of social collaboration, which will allow biotech cancer research the opportunity for the first time to become open sourced. This is accomplished by allowing our development partners the ability to protect, promote and produce their research in unified online collaboration hubs known as micro social networks. Viratech’s open source platform has integrated several intellectual property tools which, by leveraging our social collaboration network, can give our development partners a new intellectual property mechanism, which will help in addressing the protection of Intellectual Property, promotion through collaboration in our protected open source platform, and commercial development of the products achieved through collaborative research.
Using this platform, Viratech members can protect their intellectual property, then use Viratech’s micro social network as a utility to promote and crowdfund the research and development to produce the new technology.
Forward-Looking Statements
This press release includes forward-looking statements concerning the future performance of our business, its operations and its financial performance and condition, and also includes selected operating results presented without the context of accompanying financial results. These forward-looking statements include, among others, statements with respect to our objectives and strategies to achieve those objectives, as well as statements with respect to our beliefs, plans, expectations, anticipations, estimates or intentions. These forward-looking statements are based on our current expectations. We caution that all forward-looking information is inherently uncertain and actual results may differ materially from the assumptions, estimates or expectations reflected or contained in the forward-looking information, and that actual future performance will be affected by a number of factors, including economic conditions, technological change, regulatory change and competitive factors, many of which are beyond our control. Therefore, future events and results may vary significantly from what we currently foresee. We are under no obligation (and we expressly disclaim any such obligation) to update or alter the forward-looking statements whether as a result of new information, future events or otherwise.
Contact: Kevin Buckman MD
Viratech, Corp.
http://viratech.org
Email Contact: info@viratech.org